 |
PDBsum entry 1n2k
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structure of a covalent intermediate of endogenous human arylsulfatase a.
|
 |
|
Authors
|
 |
M.Chruszcz,
P.Laidler,
M.Monkiewicz,
E.Ortlund,
L.Lebioda,
K.Lewinski.
|
 |
|
Ref.
|
 |
J Inorg Biochem, 2003,
96,
386-392.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The structures of human arylsulfatase A crystals soaked in solutions containing
4-methylumbelliferyl phosphate and O-phospho-DL-tyrosine have been determined at
2.7- and 3.2-A resolution, respectively. The formylglycine in position 69, a
residue crucial for catalytic activity, was unambiguously identified in both
structures as forming a covalent bond to the phosphate moiety. A hydroxyl group
is present at the Cbeta of residue 69 and the formation of one out of two
possible stereomeric forms is strongly favoured. The structures confirm the
importance of the gem-diol intermediate in the arylsulfatase's catalytic
mechanism. The presence of an apparently stable covalent bond is consistent with
the weak phosphatase activity observed for human arylsulfatase A. The structures
of the complexes suggest that phosphate ions and phosphate esters inhibit
arylsulfatase in non-covalent and covalent modes, respectively. The metal ion
present in the active site of arylsulfatase A isolated from human placenta is
Ca(2+) and not Mg(2+) as was found in the structure of the recombinant enzyme.
|
 |
|
|
|
|
 |